Core to ProStrakan’s business strategy is the formation of partnerships, either to build and expand the product portfolio or to assist in the globalisation of existing products. This is critical to building shareholder value as well as serving our customers.

A measure of ProStrakan’s success has been our ability to attract partners who have recognised the benefits that we bring to the business relationship

· An experienced and entrepreneurial management team

· An established sales and distribution infrastructure serving European and US markets

· Focused on speciality pharmaceuticals and supported by an award winning marketing team

· A strong and proven development and regulatory capability, responsible for all drug filings

· An ethos of rapid decision-making

· A commitment to streamlined and transparent business relationships

These skills have ensured our rapid growth to date and will continue to underpin our future alliances. ProStrakan therefore welcomes the opportunity to discuss partnering opportunities that fall within our core therapeutic focus and encourage enquiries from likeminded companies who can help us globalise our expanding product portfolio.